Improved Cholesterol: Overall, the study authors noted a significant reduction in total cholesterol levels
The distribution patterns and intergroup variation of PON-1, PCT, and NLR are visually presented in the scatter matrix plot (Fig
The agency encourages healthcare providers and patients to report any adverse events related to Ozempic or Wegovy use
The second common error is the advice to "push through it" or "it will resolve on its own." While true that most GLP-1 headaches resolve by week 20, that's 4-5 months of preventable discomfort
What Doctors Recommend for Combination Therapy With this strong evidence base, providers approach the combination with specific strategies, considering individual patient factors, treatment history, and glucose control goals
The maker of Zepbound, Eli Lilly, recently announced that it will start providing 2.5 mg and 5 mg Zepbound vials directly to patients at lower prices